SABE or Normal BE? [RSABE / ABEL]

posted by jag009  – NJ, 2013-02-21 18:10 (4503 d 18:19 ago) – Posting: # 10093
Views: 12,348

Hi guys,

❝ I think it is actually quite common to see the ref-variability exceeding that of the test. While I am no CMC expert I think the originator company's production lines are often 20+ years old, while the generic company's production lines are new. And hence tablet-to-tablet variation is oftentimes better controlled by the generic company and this accounts to some degree for the observed difference in intra-subject CV's.


Just curious (or lazy). Has FDA ever published (or presented) data of withinsubject CV from test and reference from submitted full replicate studies?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
50 visitors (0 registered, 50 guests [including 13 identified bots]).
Forum time: 13:29 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5